Anna Obermayer

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial

Anna Obermayer, Norbert J. Tripolt, Peter N. Pferschy et al. · Diabetes Care · 2022 · 106 citations · Full text

Medicine, Endocrinology, Nutrition +17

Humoral immune response to <scp>COVID‐19</scp> vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective <scp>COVAC‐DM</scp> cohort study

Caren Sourij, Norbert J. Tripolt, Faisal Aziz et al. · Diabetes Obesity and Metabolism · 2022 · 64 citations · Full text

Veterinary Medicine, Immunology, Clinical Immunology +16

Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study

Felix Aberer, Othmar Moser, Faisal Aziz et al. · Diabetes Care · 2021 · 26 citations · Full text

Medicine, Immunology, Internal Medicine +13

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study

Felix Aberer, Peter N. Pferschy, Norbert J. Tripolt et al. · Diabetes Obesity and Metabolism · 2019 · 18 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)

Othmar Moser, Alexander Müller, Felix Aberer et al. · Diabetes Technology & Therapeutics · 2022 · 18 citations

Medicine, Endocrinology, Internal Medicine +13